LivaNova (LIVN) EBT (QoQ) (2015 - 2026)
LivaNova (LIVN) EBT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.77% |
| Mar 31, 2026 | -0.54% |
| Dec 31, 2025 | -18.51% |
| Sep 30, 2025 | 1.77% |
| Jun 30, 2025 | 110.56% |
| Mar 31, 2025 | -658.86% |
| Dec 31, 2024 | 27.09% |
| Sep 30, 2024 | 105.85% |
| Jun 30, 2024 | 163.13% |
| Mar 31, 2024 | 63.73% |
| Dec 31, 2023 | -4,667.24% |
| Sep 30, 2023 | -137.46% |
| Jun 30, 2023 | -45.95% |
| Mar 31, 2023 | 52.77% |
| Dec 31, 2022 | 106.03% |
| Sep 30, 2022 | -658.42% |
| Jun 30, 2022 | 241.19% |
| Mar 31, 2022 | 342.13% |
| Dec 31, 2021 | 94.47% |
| Sep 30, 2021 | 20.90% |